改善传输和促进产品市场投入之寡核苷酸治疗药物相关专家见解、最新数据、技术

Choose your language

制药业界专家发表加速产品开发的革新策略

Steve Hughes

Chief Clinical Development Officer

Ionis Pharmaceuticals, USA

Muthiah (Mano) Manoharan, PhD

Senior Vice President of Drug Discovery

Alnylam Pharmaceuticals, Inc.

Clive Meanwell

Chief Executive Officer

The Medicines Company

Arthur A. Levin

Executive Vice President, Research and Development

Avidity NanoMedicines

2018年演讲者

本学会焦点与最新主题及范例分析:

mRNA疗法
CRISPR-Cas9与基因体编辑的应用
治疗用寡核苷酸的CMC开发之风险基础方法
扩编至更大疾病族群的机会
反股寡核苷酸的立体化学控制增强了标的疗效

寡核苷酸的作用机制与活体内分布的定量
替代性制造技术降低寡核苷酸产品制造成本：酵素生产的应用
晚期药物产品开发以及药物产品制造
寡核苷酸开发的非临床个案研究
法规主管机关期许

掌握您所需的研究成果、技术、人脉加速肽制剂产品投入市场

集结300多位寡核苷酸及肽研究人员等相关企业代表。

预计将有40件以上的范例分析与最新研究数据发表。

将有超过30家以上的相关主要企业在展示会展出。

感谢EuroTIDES 2018科学谘询委员会的协助。

邀请全球寡核苷酸及肽领域主要研究人员担任演讲嘉宾并获其大力支持。

Muthiah (Mano) Manoharan, Senior VP, Drug Discovery, Alnylam Pharmaceuticals, Inc, USA
Yogesh Sanghvi, President, Rasayan, USA
Troels Koch, VP & Head of Research, RNA Therapeutics, Roche Innovation Center Copenhagen A/S, Denmark

Thomas Rupp, Owner, Thomas Rupp Consulting, Germany
Professor Cy Stein, Department of Medical Oncology and Experimental Therapeutics, City of Hope Medical Center, USA
Mike Gait, MRC Programme Leader, MRC Laboratory of Molecular Biology, UK

Dmitry Samarsky, Oligonucleotide (RNAi) Technology and Therapeutics, Experienced Executive and Industry Expert

EuroTides is an excellent business platform to meet existing and new customers in peptides and oligonucleotides development & manufacturing and at the same time learn about today's problems and tomorrow needs.

Jurgen Machielse

Business Development Director

Zeochem

Was an excellent meeting giving me the chance to hear about new developments and to interact with colleagues in a relaxed atmosphere

Anonymous

Well attended event with attendees from all parts of peptide clinical development. The talks on peptide manufacture and issues that can arise were excellent.